GlassScriptPhysician profile
Nasera Arif
NPI 1235418930
$411.64
in general payments reported to CMS, 2019-2025
8 companies · $15.19 in 2025
The $15.19 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $69.80 · 2021: $54.15 · 2022: $59.59 · 2023: $81.26 · 2024: $132 · 2025: $15.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $82.86 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $74.81 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $57.78 | 2022-2023 | Farxiga |
| Novo Nordisk INC | $56.41 | 2023-2025 | |
| Abbott Laboratories | $54.16 | 2024 | Freestyle Libre 3 |
| Corcept Therapeutics | $42.24 | 2024 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.69 | 2023 | |
| Renalytix Ai, INC. | $17.69 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasera Arif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.